CASEY LAMBERT: Open Payments
NPI 1063273605 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,391 in 178 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $4,199 · 2025 $4,391
Food & beverage: $4,391
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 68 | $1,193 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $297 |
| Madrigal Pharmaceuticals | 8 | $242 |
| Janssen Biotech, Inc. | 12 | $215 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $203 |
| GENZYME CORPORATION | 4 | $193 |
| Intercept Pharmaceuticals, Inc. | 6 | $186 |
| Phathom Pharmaceuticals, Inc. | 9 | $184 |
| Regeneron Healthcare Solutions, Inc. | 6 | $181 |
| Medtronic, Inc. | 1 | $151 |
Products named: RINVOQ, SKYRIZI, DUPIXENT, ENTYVIO, REZDIFFRA, TREMFYA, OCALIVA, VOQUEZNA.
Industry payments across LA — which companies pay providers there.
